Delivery Order SPE2DB22D2005-SPE2DB24FJEU1

Award Date 11/17/23
Potential Completion Date 11/20/23
Potential Value $11K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $30,478.07 and an ultimate completion date of September 13, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
The federal contract award summarized is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $11,388.64. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,803.69 and an ultimate completion date of April 15, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open...
This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract, valued at $1,951.13, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 26, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order with a firm fixed price of $3,653.48 and a completion date of May 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $3,627.34, was awarded by the Defense Logistics Agency (DLA) and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of May 6, 2024. This award is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $1,198.16 and a completion date of September 5, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of...
This federal contract award is for the delivery of NARCAN 4 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,344.97, is a firm fixed-price delivery order with a completion date of January 30, 2023. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
This federal contract award is for the supply of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with no set-aside designation. The contract has a ceiling value of $16,835.44 and an ultimate completion date of February 27, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has established itself as a key vendor for...
This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract, valued at $2,370.73, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 13, 2023. No set-aside designation was used for this award. Amerisourcebergen holds a...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJEU1
    Delivery Order

This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $11,134.94 and a completion date of November 20, 2023. This contract is a delivery order placed against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 5/12/25, 10:20 AM